• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors of COVID-19 infection and hospitalization in group homes for individuals with intellectual and/or developmental disabilities.具有智力和/或发育障碍的个体群体之家中 COVID-19 感染和住院的预测因素。
Disabil Health J. 2024 Oct;17(4):101645. doi: 10.1016/j.dhjo.2024.101645. Epub 2024 Jun 5.
2
Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trial.减少严重精神疾病和智力及发育障碍个体群体住宅中 COVID-19 的最佳实践:混合 1 型有效性实施整群随机试验方案。
Contemp Clin Trials. 2023 Feb;125:107053. doi: 10.1016/j.cct.2022.107053. Epub 2022 Dec 17.
3
COVID-19-Related Outcomes Among Group Home Residents with Serious Mental Illness in Massachusetts in the First Year of the Pandemic.大流行第一年马萨诸塞州群居之家严重精神疾病患者的 COVID-19 相关结局。
Adm Policy Ment Health. 2024 Jan;51(1):60-68. doi: 10.1007/s10488-023-01311-9. Epub 2023 Nov 8.
4
Tailored vs. General COVID-19 prevention for adults with mental disabilities residing in group homes: a randomized controlled effectiveness-implementation trial.针对群居的成年精神残障人士的个体化与一般化 COVID-19 预防措施比较:一项随机对照有效性-实施试验。
BMC Public Health. 2024 Jun 26;24(1):1705. doi: 10.1186/s12889-024-18835-w.
5
Supporting individuals with intellectual and developmental disability during the first 100 days of the COVID-19 outbreak in the USA.在 COVID-19 疫情在美国暴发的头 100 天期间,为智力和发育障碍者提供支持。
J Intellect Disabil Res. 2020 Jul;64(7):489-496. doi: 10.1111/jir.12740. Epub 2020 Jun 3.
6
Covid-19 patterns among adults with intellectual and developmental disability and the general population in New York state during the first year of the pandemic.大流行第一年纽约州成年智障和发育障碍患者与普通人群中的新冠病毒流行模式。
Disabil Health J. 2024 Jul;17(3):101623. doi: 10.1016/j.dhjo.2024.101623. Epub 2024 Apr 9.
7
Group Home Staff Experiences With Work and Health in the COVID-19 Pandemic in Massachusetts.马萨诸塞州群体家庭工作人员在 COVID-19 大流行期间的工作和健康体验。
JAMA Health Forum. 2023 Apr 7;4(4):e230445. doi: 10.1001/jamahealthforum.2023.0445.
8
Risk Factors Associated With COVID-19 Outcomes Among People With Intellectual and Developmental Disabilities Receiving Residential Services.与接受住宿服务的智力和发育障碍者的 COVID-19 结局相关的风险因素。
JAMA Netw Open. 2021 Jun 1;4(6):e2112862. doi: 10.1001/jamanetworkopen.2021.12862.
9
COVID-19 outcomes among people with intellectual and developmental disability living in residential group homes in New York State.纽约州居住在集体住宅中的智障和发育障碍患者的 COVID-19 结局。
Disabil Health J. 2020 Oct;13(4):100969. doi: 10.1016/j.dhjo.2020.100969. Epub 2020 Jun 24.
10
Time-varying associations between COVID-19 case incidence and community-level sociodemographic, occupational, environmental, and mobility risk factors in Massachusetts.马萨诸塞州 COVID-19 病例发生率与社区层面社会人口统计学、职业、环境和流动性风险因素的时变关联。
BMC Infect Dis. 2021 Jul 16;21(1):686. doi: 10.1186/s12879-021-06389-w.

本文引用的文献

1
Understanding covid-19 outcomes among people with intellectual disabilities in England.了解英格兰智障人群中新冠病毒的结果。
BMC Public Health. 2023 Oct 25;23(1):2099. doi: 10.1186/s12889-023-16993-x.
2
Group Home Staff Experiences With Work and Health in the COVID-19 Pandemic in Massachusetts.马萨诸塞州群体家庭工作人员在 COVID-19 大流行期间的工作和健康体验。
JAMA Health Forum. 2023 Apr 7;4(4):e230445. doi: 10.1001/jamahealthforum.2023.0445.
3
Best practices to reduce COVID-19 in group homes for individuals with serious mental illness and intellectual and developmental disabilities: Protocol for a hybrid type 1 effectiveness-implementation cluster randomized trial.减少严重精神疾病和智力及发育障碍个体群体住宅中 COVID-19 的最佳实践:混合 1 型有效性实施整群随机试验方案。
Contemp Clin Trials. 2023 Feb;125:107053. doi: 10.1016/j.cct.2022.107053. Epub 2022 Dec 17.
4
Examining the development and utilization of infection control policies to safely support adults with intellectual and developmental disabilities in congregate living settings during COVID-19.研究感染控制政策的制定和利用,以在 COVID-19 期间安全地支持集体居住环境中的智障和发育障碍成年人。
Can J Public Health. 2022 Dec;113(6):918-929. doi: 10.17269/s41997-022-00674-0. Epub 2022 Sep 6.
5
Addressing COVID-19 Testing Inequities Among Underserved Populations in Massachusetts: A Rapid Qualitative Exploration of Health Center Staff, Partner, and Resident Perceptions.解决马萨诸塞州服务不足人群中的 COVID-19 检测不公平问题:对医疗中心工作人员、合作伙伴和居民看法的快速定性探索。
Front Public Health. 2022 Mar 24;10:838544. doi: 10.3389/fpubh.2022.838544. eCollection 2022.
6
Overcrowded housing increases risk for COVID-19 mortality: an ecological study.过度拥挤的住房增加了 COVID-19 死亡率的风险:一项生态学研究。
BMC Res Notes. 2022 Apr 5;15(1):126. doi: 10.1186/s13104-022-06015-1.
7
COVID-19 positivity rates, hospitalizations and mortality of adults with and without intellectual and developmental disabilities in Ontario, Canada.加拿大安大略省有和没有智力和发育障碍的成年人的 COVID-19 阳性率、住院率和死亡率。
Disabil Health J. 2022 Jan;15(1):101174. doi: 10.1016/j.dhjo.2021.101174. Epub 2021 Jul 26.
8
Factors Associated With Racial Differences in Deaths Among Nursing Home Residents With COVID-19 Infection in the US.与美国感染 COVID-19 的养老院居民的死亡中存在种族差异相关的因素。
JAMA Netw Open. 2021 Feb 1;4(2):e2037431. doi: 10.1001/jamanetworkopen.2020.37431.
9
Residential context and COVID-19 mortality among adults aged 70 years and older in Stockholm: a population-based, observational study using individual-level data.斯德哥尔摩 70 岁及以上成年人的居住环境与 COVID-19 死亡率:一项基于人群的、使用个体水平数据的观察性研究。
Lancet Healthy Longev. 2020 Nov;1(2):e80-e88. doi: 10.1016/S2666-7568(20)30016-7. Epub 2020 Oct 27.
10
COVID-19 outcomes among people with intellectual and developmental disability in California: The importance of type of residence and skilled nursing care needs.加利福尼亚州智障和发育障碍人群的 COVID-19 结局:居住类型和熟练护理需求的重要性。
Disabil Health J. 2021 Apr;14(2):101051. doi: 10.1016/j.dhjo.2020.101051. Epub 2020 Dec 5.

具有智力和/或发育障碍的个体群体之家中 COVID-19 感染和住院的预测因素。

Predictors of COVID-19 infection and hospitalization in group homes for individuals with intellectual and/or developmental disabilities.

机构信息

Massachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA; Massachusetts General Hospital, Department of Medicine, 55 Fruit St, Gray 7-730, Boston, MA, 02114, USA; Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA.

Massachusetts General Hospital, Mongan Institute, 100 Cambridge St, Suite 1600, Boston, MA, 02114, USA; Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA.

出版信息

Disabil Health J. 2024 Oct;17(4):101645. doi: 10.1016/j.dhjo.2024.101645. Epub 2024 Jun 5.

DOI:10.1016/j.dhjo.2024.101645
PMID:38879412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11454325/
Abstract

BACKGROUND

More than seven million people with intellectual and/or developmental disabilities (ID/DD) live in the US and may face an elevated risk for COVID-19.

OBJECTIVE

To identify correlates of COVID-19 and related hospitalizations among people with ID/DD in group homes in Massachusetts.

METHODS

We collected data during March 1, 2020-June 30, 2020 (wave 1) and July 1, 2020-March 31, 2021 (wave 2) from the Massachusetts Department of Public Health and six organizations administering 206 group homes for 1035 residents with ID/DD. The main outcomes were COVID-19 infections and related hospitalizations. We fit multilevel Cox proportional hazards models to estimate associations with observed predictors and assess contextual home- and organizational-level effects.

RESULTS

Compared with Massachusetts residents, group home residents had a higher age-adjusted rate of COVID-19 in wave 1 (incidence rate ratio [IRR], 12.06; 95 % confidence interval [CI], 10.51-13.84) and wave 2 (IRR, 2.47; 95 % CI, 2.12-2.88) and a higher age-adjusted rate of COVID-19 hospitalizations in wave 1 (IRR, 17.64; 95 % CI, 12.59-24.70) and wave 2 (IRR, 4.95; 95 % CI, 3.23-7.60). COVID-19 infections and hospitalizations were more likely among residents aged 65+ and in group homes with 6+ resident beds and recent infection among staff and residents.

CONCLUSIONS

Aggressive efforts to decrease resident density, staff-to-resident ratios, and staff infections through efforts such as vaccination, in addition to ongoing access to personal protective equipment and COVID-19 testing, may reduce COVID-19 and related hospitalizations in people with ID/DD living in group homes.

摘要

背景

美国有超过 700 万患有智力和/或发育障碍 (ID/DD) 的人,他们可能面临更高的 COVID-19 风险。

目的

确定马萨诸塞州群体家庭中 ID/DD 患者 COVID-19 感染及相关住院的相关因素。

方法

我们于 2020 年 3 月 1 日至 6 月 30 日(第 1 波)和 2020 年 7 月 1 日至 2021 年 3 月 31 日(第 2 波)期间从马萨诸塞州公共卫生部和六个管理 206 个 ID/DD 居民群体家庭的组织收集数据。主要结局为 COVID-19 感染和相关住院。我们拟合多水平 Cox 比例风险模型,以估计与观察到的预测因素的关联,并评估家庭和组织层面的背景效应。

结果

与马萨诸塞州居民相比,群体家庭居民在第 1 波(调整年龄后的发病率比 [IRR],12.06;95%置信区间 [CI],10.51-13.84)和第 2 波(IRR,2.47;95%CI,2.12-2.88)的 COVID-19 感染率更高,第 1 波(IRR,17.64;95%CI,12.59-24.70)和第 2 波(IRR,4.95;95%CI,3.23-7.60)的 COVID-19 住院率也更高。年龄在 65 岁及以上的居民以及居民床位在 6 张及以上的群体家庭以及工作人员和居民最近感染的居民中,COVID-19 感染和住院的可能性更大。

结论

通过接种疫苗等努力降低居民密度、工作人员与居民的比例以及工作人员感染,以及持续获得个人防护设备和 COVID-19 检测,可能会降低居住在群体家庭中的 ID/DD 患者的 COVID-19 和相关住院率。